Fox Run Management L.L.C. Sells 3,278 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC)

Fox Run Management L.L.C. cut its holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) by 46.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,837 shares of the company's stock after selling 3,278 shares during the period. Fox Run Management L.L.C.'s holdings in iRhythm Technologies were worth $346,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. State Street Corp lifted its holdings in shares of iRhythm Technologies by 1.3% in the third quarter. State Street Corp now owns 908,843 shares of the company's stock worth $67,473,000 after buying an additional 11,992 shares in the last quarter. Braidwell LP lifted its stake in iRhythm Technologies by 48.7% in the 3rd quarter. Braidwell LP now owns 782,557 shares of the company's stock worth $58,097,000 after purchasing an additional 256,200 shares in the last quarter. Eventide Asset Management LLC boosted its holdings in iRhythm Technologies by 170.8% in the 3rd quarter. Eventide Asset Management LLC now owns 736,721 shares of the company's stock valued at $54,694,000 after purchasing an additional 464,629 shares during the period. Geode Capital Management LLC grew its position in shares of iRhythm Technologies by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 733,308 shares of the company's stock valued at $54,451,000 after purchasing an additional 5,423 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in shares of iRhythm Technologies by 9.6% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 570,048 shares of the company's stock valued at $50,991,000 after purchasing an additional 50,075 shares in the last quarter.

Remove Ads

iRhythm Technologies Trading Down 1.0 %

Shares of IRTC stock traded down $1.11 on Friday, hitting $105.00. 233,597 shares of the company's stock traded hands, compared to its average volume of 461,972. The stock has a market capitalization of $3.30 billion, a price-to-earnings ratio of -28.85 and a beta of 1.36. The company's fifty day simple moving average is $108.09 and its 200 day simple moving average is $90.16. iRhythm Technologies, Inc. has a one year low of $55.92 and a one year high of $128.52. The company has a debt-to-equity ratio of 9.00, a quick ratio of 6.12 and a current ratio of 6.27.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.29) by $0.30. The firm had revenue of $164.33 million for the quarter, compared to analysts' expectations of $158.30 million. iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. Equities analysts forecast that iRhythm Technologies, Inc. will post -1.98 EPS for the current year.

Wall Street Analyst Weigh In

IRTC has been the subject of several research analyst reports. Truist Financial lifted their price objective on iRhythm Technologies from $111.00 to $145.00 and gave the company a "buy" rating in a research note on Friday, February 21st. Canaccord Genuity Group lifted their price target on iRhythm Technologies from $125.00 to $152.00 and gave the company a "buy" rating in a research report on Monday, December 9th. The Goldman Sachs Group upped their price objective on shares of iRhythm Technologies from $91.00 to $124.00 and gave the stock a "neutral" rating in a research report on Monday, February 24th. Oppenheimer lifted their target price on shares of iRhythm Technologies from $105.00 to $120.00 and gave the company an "outperform" rating in a research report on Wednesday, January 8th. Finally, Needham & Company LLC boosted their price target on shares of iRhythm Technologies from $125.00 to $138.00 and gave the stock a "buy" rating in a research note on Friday, February 21st. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat.com, iRhythm Technologies currently has a consensus rating of "Moderate Buy" and an average target price of $119.73.

iRhythm Technologies Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.